Cite
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. (Stomach)
MLA
Labenz, J., et al. “Primary Prevention of Diclofenac Associated Ulcers and Dyspepsia by Omeprazole or Triple Therapy in Helicobacter Pylori Positive Patients: A Randomised, Double Blind, Placebo Controlled, Clinical Trial. (Stomach).” Gut, vol. 51, no. 3, Sept. 2002, p. 329. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.91137846&authtype=sso&custid=ns315887.
APA
Labenz, J., Blum, A. L., Bolten, W. W., Dragosics, B., Rosch, W., Stolte, M., & Koelz, H. R. (2002). Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. (Stomach). Gut, 51(3), 329.
Chicago
Labenz, J., A.L. Blum, W.W. Bolten, B. Dragosics, W. Rosch, M. Stolte, and H.R. Koelz. 2002. “Primary Prevention of Diclofenac Associated Ulcers and Dyspepsia by Omeprazole or Triple Therapy in Helicobacter Pylori Positive Patients: A Randomised, Double Blind, Placebo Controlled, Clinical Trial. (Stomach).” Gut 51 (3): 329. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.91137846&authtype=sso&custid=ns315887.